SEC Info - Valera Pharmaceuticals Inc - IPO: ‘S-1/A’ on 1/17/06

SEC Info℠

Home

Help

Please Sign In

Valera Pharmaceuticals Inc – IPO: ‘S-1/A’ on 1/17/06

On: Tuesday, 1/17/06, at 1:47pm ET · Private-to-Public: Document/Exhibit `¶` – Release Delayed · Accession #: 950123-6-417 · File #: 333-123288

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/17/06  Valera Pharmaceuticals Inc        S-1/A¶                 9:1.5M                                   Donnelley … Solutions/FA

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Amendment No. 5 to Form S-1                         HTML   1.07M 
 9: CORRESP   ¶ Comment-Response or Other Letter to the SEC         HTML     20K 
 2: EX-1.1      Ex-1.1: Form of Underwriting Agreement                43    176K 
 3: EX-3.2      Ex-3.2: Certificate of Amendment                       3      8K 
 4: EX-3.3      Ex-3.3: Amended and Restated Certification of          8     30K 
                          Incorporation                                          
 5: EX-3.5      Ex-3.5: Amended and Restated Bylaws                   20    102K 
 6: EX-4.1      Ex-4.1: Specimen Common Stock Certificate           HTML     20K 
 7: EX-5.1      Ex-5.1: Opinion of Pepper Hamilton LLP                 2     14K 
 8: EX-23.1     Ex-23.1: Consent of Ernst & Young LLP               HTML      6K

Filing Submission 0000950123-06-000417 – SGML Text

Original SGML Text submitted by:	Donnelley Financial Solutions/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 1.5M ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20190428-210555	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20190428-210555	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20060117-134718	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0000950123-06-000417
<TYPE>				S-1/A
<PUBLIC-DOCUMENT-COUNT>		11
<FILING-DATE>			20060117
<DATE-OF-FILING-DATE-CHANGE>	20060117

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		Valera Pharmaceuticals Inc
<CIK>				0001305409
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			000000000
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			S-1/A
<ACT>				33
<FILE-NUMBER>			333-123288
<FILM-NUMBER>			06532487
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			8 CLARKE DR
<CITY>				CRANBURY
<STATE>				NJ
<ZIP>				08512
<PHONE>				609-409-9010
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			8 CLARKE DR
<CITY>				CRANBURY
<STATE>				NJ
<ZIP>				08512
</MAIL-ADDRESS>
</FILER>

<DOCUMENT>
<TYPE>		S-1/A
<SEQUENCE>	1
<FILENAME>	y06541a5sv1za.htm
<DESCRIPTION>	AMENDMENT NO. 5 TO FORM S-1
<TEXT>
<HTML>
       Show <HTML>: 36,819 lines (widest: 209 characters) - 1.3M bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-1.1
<SEQUENCE>	2
<FILENAME>	y06541a5exv1w1.txt
<DESCRIPTION>	EX-1.1: FORM OF UNDERWRITING AGREEMENT
<TEXT>
       Show <TEXT>: 2,114 lines (widest: 80 characters) - 131K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-3.2
<SEQUENCE>	3
<FILENAME>	y06541a5exv3w2.txt
<DESCRIPTION>	EX-3.2: CERTIFICATE OF AMENDMENT
<TEXT>
       Show <TEXT>: 85 lines (widest: 80 characters) - 5K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-3.3
<SEQUENCE>	4
<FILENAME>	y06541a5exv3w3.txt
<DESCRIPTION>	EX-3.3: AMENDED AND RESTATED CERTIFICATION OF INCORPORATION
<TEXT>
       Show <TEXT>: 366 lines (widest: 80 characters) - 22K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-3.5
<SEQUENCE>	5
<FILENAME>	y06541a5exv3w5.txt
<DESCRIPTION>	EX-3.5: AMENDED AND RESTATED BYLAWS
<TEXT>
       Show <TEXT>: 1,082 lines (widest: 80 characters) - 66K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.1
<SEQUENCE>	6
<FILENAME>	y06541a5exv4w1.htm
<DESCRIPTION>	EX-4.1: SPECIMEN COMMON STOCK CERTIFICATE
<TEXT>
<HTML>
       Show <HTML>: 639 lines (widest: 1,341 characters) - 24K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-5.1
<SEQUENCE>	7
<FILENAME>	y06541a5exv5w1.txt
<DESCRIPTION>	EX-5.1: OPINION OF PEPPER HAMILTON LLP
<TEXT>
       Show <TEXT>: 94 lines (widest: 80 characters) - 5K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-23.1
<SEQUENCE>	8
<FILENAME>	y06541a5exv23w1.htm
<DESCRIPTION>	EX-23.1: CONSENT OF ERNST & YOUNG LLP
<TEXT>
<HTML>
       Show <HTML>: 44 lines (widest: 165 characters) - 2K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	10  ⇒ 9  ⇐ Not a Document/Exhibit
<FILENAME>	y06541a5y0654100.gif
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 60 lines (Unix-to-Unix encoding) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	11  ⇒ 10  ⇐ Not a Document/Exhibit
<FILENAME>	y06541a5y0654102.gif
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 811 lines (Unix-to-Unix encoding) - 49K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<PRIVATE-TO-PUBLIC>		20060926-115003	 ⇐ Metadata from SEC Info (ET)
<TYPE>		CORRESP
<SEQUENCE>	12  ⇒ 11  ⇐ Document/Exhibit 9
<FILENAME>	filename12.htm
<TEXT>
<HTML>
       Show <HTML>: 596 lines (widest: 188 characters) - 21K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0000950123-06-000417 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Valera Pharmaceuticals Inc – IPO: ‘S-1/A’ on 1/17/06

On: Tuesday, 1/17/06, at 1:47pm ET · Private-to-Public: Document/Exhibit ¶ – Release Delayed · Accession #: 950123-6-417 · File #: 333-123288

Previous ‘S-1’: ‘S-1/A’ on 12/9/05 · Next & Latest: ‘S-1/A’ on 1/30/06

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1Filing Table of Contents

On: Tuesday, 1/17/06, at 1:47pm ET · Private-to-Public: Document/Exhibit `¶` – Release Delayed · Accession #: 950123-6-417 · File #: 333-123288

Initial Public Offering (IPO): Pre-Effective Amendment to Registration Statement (General Form) — Form S-1
Filing Table of Contents